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Background: We examined whether renal resistive index (RI), a simple index of renal vascular resistance, is associated
with the presence and severity of anemia, and can predict the future development of anemia in patients with
hypertension.
Methods: We retrospectively examined 175 patients with hypertension (mean age 67 ± 11 years, 32-85 years,
134 males) who underwent renal ultrasonography. Anemia was defined as a reduction in the concentration of
hemoglobin <13.0 g/dL for men and <12.0 g/dL for women. Renal RI was measured in the interlobar arteries.
Results: Anemia was present in 37% of men and 34% of women. The mean estimated glomerular filtration rate
(eGFR) was 58 ± 23 ml/min/1.73 m2 (median: 56 ml/min/1.73 m2, range: 16-168 ml/min/1.73 m2) and the mean
renal RI was 0.70 ± 0.09 (median: 0.70, range: 0.45-0.92). Proteinuria was present in 29% of patients. Both eGFR
and renal RI correlated significantly with hemoglobin levels. In the stepwise multivariate linear regression analysis,
renal RI was associated with hemoglobin levels independently of potential confounders including eGFR. During
the follow-up period (median: 959 days, range: 7-3595 days), Kaplan–Meier curves demonstrated that patients
with renal RI above the median value had a higher incidence of the future development of anemia than other
patients. Cox regression analysis showed that renal RI (hazard ratio 1.18, 95% CI 1.02-1.37 per 0.05 rises in renal RI,
p =0.03) and the presence of proteinuria were (hazard ratio 1.80, 95% CI 1.08-3.01, p =0.03) were independently
associated with the future development of anemia after correcting for confounding factors.
Conclusions: Measurement of renal RI can be useful for elucidating the pathogenesis of anemia and for inferring
its potential risk in patients with hypertension.
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Chronic kidney disease (CKD) is known to cause anemia
mainly due to inappropriate erythropoietin (EPO) secre-
tion [1,2], especially in patients with end-stage renal fail-
ure. However, anemia can occur early in the development
of CKD, defined on the basis of the estimated glomerular
filtration rate (eGFR). This indicates that the progression
of renal anemia is not governed solely by glomerular* Correspondence: dohik@clin.medic.mie-u.ac.jp
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identified in the renal tubulointerstitium surrounding the
central vessels, not in the glomeruli [4,5]. Thus, unfavor-
able changes in the interstitial microenvironment, such as
inflammation, oxidative stress and ischemia, can impair
the function of EPO-producing cells. Recently, Souma
et al. demonstrated that the phenotypic transition of EPO-
producing cells to non-EPO-producing myofibroblasts is
modulated by inflammatory molecules, and suggested the
connection between anemia and renal fibrosis in CKD in a
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sociated with arteriosclerosis, interstitial inflammation
and fibrosis, as well as tubular insufficiency secondary to
endothelial dysfunction and progressive infiltration of
macrophages and T cells to the perivascular interstitium
induced by chronic exposure to high blood pressure
[7-10]. Therefore, the development of renal damage can
contribute to the pathogenesis of anemia, even in earlier
stages of CKD in patients with hypertension.
Renal resistive index (RI) in the intra-renal arteries at
the level of the corticomedullary junction using pulsed
Doppler ultrasonography is a simple index of renal vas-
cular resistance [11,12], and high renal RI is known to
be associated with severe interstitial fibrosis, arterioscler-
osis and renal function decline [13-15].
Accordingly, we examined whether renal RI is associ-
ated with the presence and severity of anemia, and
whether high renal RI predicts the future development
of anemia in patients with hypertension.
Methods
Study population
We retrospectively reviewed patients with hypertension
who underwent renal ultrasonography for the screening
of renal artery stenosis and the evaluation of renal ar-
teriosclerosis at their physician’s discretion on the basis
of their age, comorbidity and disease characteristics in
Mie University Hospital between April 2004 and June
2012. Among them, we selected 175 subjects (mean age
67 ± 11 years, range 32-85 years, 134 males) after exclud-
ing patients with atrial fibrillation, moderate to severe
aortic valvular heart diseases, congestive heart failure,
primary glomerular and tubulointerstitial disease of the
kidney, hydronephrosis, nephrotic syndrome, renal artery
stenosis, and diseases or conditions that could cause or
improve anemia (such as advanced cancers, hematologic
disorders, autoimmune diseases and active bleeding). Pa-
tients receiving hemodialysis or erythropoiesis-stimulating
agent therapy were also excluded.
Clinical evaluation
Anemia was defined as a reduction in the concentration of
hemoglobin in a sample of venous blood when compared
with reference values (<12.0 g/dl for women and <13.0 g/dl
for men) [16]. CKD was defined as the presence of
eGFR <60 ml/min/1.73 m2 for 3 months or more. The
eGFR of each patient was calculated from their serum
creatinine (SCr) value and their age using the following
equation: eGFR (ml/min/1.73 m2) = 194 × Age-0.287 ×
SCr-1.094 (if female × 0.739) [17]. Urine proteins were
qualified by using a dipstick test. All patients were evalu-
ated for the presence of coexisting traditional risk factors
for atherosclerosis. Diabetes mellitus was determined under
the following conditions: fasting glucose level >125 mg/dl,casual plasma glucose concentration >200 mg/dl in the
presence of symptoms, 2-hour oral glucose tolerance test
value of >200 mg/dl or if the patient was using antidiabetic
agents, including insulin [18]. Hypertension was deter-
mined under the following conditions: systolic blood pres-
sure ≥140 mmHg or diastolic blood pressure ≥90 mmHg,
or if the patient was receiving antihypertensive therapy [19].
Dyslipidemia was determined under the following condi-
tions: low-density-lipoprotein cholesterol level ≥140 mg/dl,
triglyceride level ≥150 mg/dl, high-density-lipoprotein
cholesterol level <40 mg/dl or receiving antidyslipi-
demic medication [20]. Finally, chronic obstructive pul-
monary disease (COPD) was diagnosed on the basis of
a post-bronchodilator forced expiratory volume in one
second (FEV1)/forced vital capacity (FVC) value of <70
[21]. The protocol was approved by the Human Studies
Subcommittee of Mie University Graduate School of
Medicine.
Renal doppler ultrasonography
First, the flow velocities in the aorta and renal arteries
were evaluated to rule out morphological abnormality or
renal artery stenosis. Second, the renal RI was deter-
mined in the interlobar arteries of both kidneys and
expressed as the mean of these values. The digital diag-
nostic ultrasound systems used were the Aplio XG SSA-
790A with a PVT-375BT convex array transducer
(Toshiba Medical Systems, Otawara, Tochigi, Japan) op-
erating at a frequency of 3.5 MHz, and the LOGIQ P6
with a 4C convex array transducer (GE Medical Systems,
Milwaukee, WI, US) operating in the frequency range of
4.0 MHz to 5.5 MHz. The ultrasound examinations were
performed by two well-trained technicians. Renal RI was
calculated as follows (Figure 1):
RenalRI = (peak systolic velocity − end diastolic velocity)/
peak systolic velocity [22,23].
Clinical outcome
Medical records were retrospectively reviewed for each
patient. The study end-point was 1) new anemia
(<12.0 g/dl for women and <13.0 g/dl for men) for non-
anemic patients, and 2) decreased hemoglobin levels
greater than 1 g/dl and/or initiation of treatment includ-
ing iron supplementation and EPO-stimulating agents
for anemic patients. Anemic events within 3 months
after minor surgery or cardiac catheterization and within
6 months after major surgery were excluded from the
analysis.
Statistical analysis
All continuous variables were approximately normally
distributed and presented as the mean ± standard devi-
ation. In order to assess differences between the two
groups, Pearson’s chi-square test was used for nominal
Figure 1 Example of renal resistive index measurement. Pulsed
Doppler ultrasonography was obtained in the intra-renal artery at the
level of the corticomedullary junction. Renal resistive index is measured
as {peak systolic velocity (a) - end diastolic velocity (b)} / peak systolic
velocity (a).
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make comparisons among three groups, we used Bonfer-
roni’s multivariate comparison test. The linear correlations
between the variables were parametrically evaluated using
Pearson’s product moment correlation coefficient. We
performed stepwise multivariate linear regression analysis
to determine independent predictors of hemoglobin levels.
Moreover, we examined the predictive value of potential
clinical parameters for the study end-point, namely, the
future development of anemia. Cumulative event rates
were assessed using the Kaplan–Meier method and com-
pared using the log-rank test. The impact of clinical pre-
dictors on the future development of anemia was assessed
by univariate and multivariate Cox proportional hazards
regression. Hazard ratios are given with 95% confidence
intervals (CI). Reliability was assessed by calculating
intraobserver and interobserver intraclass correlation coef-
ficients. For all tests, a p value <0.05 was considered statis-
tically significant. Data were analyzed using SPSS Statistics
for Windows (Version 20.0, IBM Corp., Armonk, NY, US).Results
Patient characteristics
Patient characteristics are presented in Table 1.
Hemoglobin level ranged from 7.3 to 17.2 g/dL, and
anemia was present in 37% of men and 34% of women.
Among all 175 patients, eGFR ranged from 16 to
168 ml/min/1.73 m2, and 102 patients (58%) had an
eGFR of less than 60 ml/min/1.73 m2. Only 19 patients
(11%) had an eGFR of less than 30 ml/min/1.73 m2.
Fifty-one patients (29%) had a positive reaction in the
urine protein test. The prevalence rates of coexisting
diabetes mellitus, dyslipidemia and coronary artery dis-
eases were 52%, 70% and 59%, respectively. When all
subjects were divided into two groups according to the
presence of anemia (Table 1), those with anemia were
older, had greater body mass index (BMI), lower dia-
stolic blood pressure, higher pulse pressure, higher renal
RI, lower eGFR and higher prevalence of proteinuria
than those without it. Patients with anemia were also
more likely to receive renin-angiotensin-aldosterone sys-
tem (RAAS) inhibitors and calcium channel blockers than
those without it. There were statistically significant posi-
tive correlations between renal RI and pulse pressure, one
of the surrogate measures of large artery stiffness (r = 0.45,
p < 0.05), and age (r = 0.42, p < 0.05).
The relationships of eGFR and Renal RI to hemoglobin levels
All patients underwent successful renal Doppler ultrason-
ography, and the mean renal RI was 0.70 ± 0.09 (median:
0.70, range: 0.45-0.92). The measurements of renal RI
were reproducible with intraobserver and interobserver
intraclass correlation coefficients of 0.96 (p < 0.01) and
0.90 (p < 0.01), respectively. Figure 2 shows the relation-
ships of renal RI and eGFR with hemoglobin levels. Both
renal RI and eGFR had statistically significant correlations
with hemoglobin levels. Further analysis revealed that
there were significant correlations between renal RI and
hemoglobin levels in the subgroups of 30 ≤ eGFR <60 ml/
min/1.73 m2 (r = -0.42, p < 0.05) and eGFR ≥60 ml/min/
1.73 m2 (r = -0.24, p < 0.05) but not eGFR <30 ml/min/
1.73 m2 (r = -0.11, p = ns). In addition, we assessed the re-
lationship between renal RI and hemoglobin level in
each stage of CKD with box and whisker plots (Figure 3).
Bonferroni’s multivariate comparison test showed that
there was a significant difference in the hemoglobin levels
between patients with renal RI higher than the median
value (0.70) and those with renal RI ≤0.7 only in the sub-
group of 30 ≤ eGFR <60 ml/min/1.73 m2. Subsequently,
univariate and stepwise multivariate linear regression ana-
lyses were applied to assess the relationships between
hemoglobin levels and clinical variables (p < 0.1 for entry
in Table 1: age, sex, BMI, diastolic blood pressure, pulse
pressure, renal RI, eGFR, urine protein and administration
of RAAS inhibitors and calcium channel blockers). As a
Table 1 Patient characteristics and comparison between patients with and without anemia
All Anemia No anemia p value
Demographic data
Number 175 64 111
Age, years 67 ± 11 71 ± 10 65 ± 11 <0.01
Males, number (%) 134 (76.6) 50 (78.1) 84 (75.7) 0.71
Body mass index, kg/m2 24.2 ± 3.9 23.7 ± 4.5 24.6 ± 3.5 0.02
Systolic blood pressure, mmHg 135 ± 18 137 ± 20 135 ± 17 0.59
Diastolic blood pressure, mmHg 75 ± 13 72 ± 14 76 ± 13 0.01
Pulse pressure, mmHg 61 ± 15 64 ± 17 59 ± 14 0.02
Heart rate, bpm 67 ± 11 67 ± 10 67 ± 12 0.98
Resistive index 0.70 ± 0.09 0.74 ± 0.09 0.67 ± 0.08 <0.01
Left ventricular ejection fraction 0.63 ± 0.12 0.63 ± 0.14 0.64 ± 0.11 0.92
Laboratory data
Hemoglobin, g/dl 13.1 ± 1.7 11.4 ± 1.0 14.1 ± 1.2 <0.01
Estimated GFR, ml/min./1.73 m2 57.7 ± 23.1 48.3 ± 24.8 63.1 ± 20.3 <0.01
Qualitative urine protein, number (%) 51 (29.3) 31 (49.2) 20 (18.0) <0.01
Hemoglobin A1c, % 6.4 ± 1.7 6.6 ± 2.1 6.4 ± 1.4 0.98
Comorbidities, number (%)
Diabetes mellitus 91 (52.0) 35 (54.7) 56 (50.5) 0.60
Dyslipidemia 122 (69.7) 46 (71.9) 76 (68.5) 0.64
Coronary artery disease 104 (59.4) 41 (64.1) 63 (56.8) 0.34
Peripheral artery disease 34 (19.4) 16 (25.0) 18 (16.2) 0.16
History of congestive heart failure 12 (6.8) 6 (9.4) 6 (5.4) 0.35
History of cerebral infarction 26 (14.9) 12 (18.8) 14 (12.6) 0.30
Current smoking 53 (30.6) 19 (30.2) 34 (30.9) 0.92
COPD 8 (4.6) 4 (3.6) 4 (6.3) 0.41
Medications, number (%)
RAAS inhibitors 125 (71.4) 52 (81.3) 73 (65.8) 0.02
Calcium channel blockers 114 (65.1) 47 (73.4) 67 (60.4) 0.07
Beta blockers 57 (32.6) 17 (26.6) 40 (36.0) 0.20
Statins 92 (52.6) 37 (57.8) 55 (49.5) 0.29
Values are expressed as mean ± SD or numbers and percentages. Student’s t test was used to assess differences between the two groups except for sex,
qualitative urine protein, comorbidities and medications, for which chi-square test was used.
GFR, glomerular filtration rate; COPD, chronic obstructive pulmonary disease; RAAS, renin-angiotensin-aldosterone system.
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associated with hemoglobin level (Table 2).
Predictive value of Renal RI for the future development of
anemia
Among all 175 patients, we were able to perform follow-up
evaluations on 174 (99%) of them. During the follow-up
period (median 959 days, range: 7-3595 days), 84 (48%)
patients developed anemia (new anemia in 48 patients,
further development of anemia in 32 patients, initiation
of iron supplementation in 2 patients and initiation of
EPO in 2 patients). There was no relationship between
the change in hemoglobin level and change in eGFRduring the follow-up period. We performed Cox regres-
sion analysis in order to determine whether indices of
renal damage including renal RI, eGFR and urine pro-
tein have potential to predict the future development of
anemia. In terms of the results, renal RI per 0.05 rises
and the presence of urine protein were independent
predictors of the future development of anemia after
correcting for sex, diabetes mellitus and baseline
anemia (Table 3).
Kaplan–Meier curves demonstrated that patients with
renal RI higher than the median value (0.70) in both the
non-anemic and the anemic subgroups had a higher inci-
dence of the future development of anemia than those with
Figure 2 The relationships between hemoglobin levels and estimated glomerular filtration rate and renal resistive index. Scatter plots
showing the relationships between hemoglobin levels and estimated glomerular filtration rate (left) and renal resistive index (right) in all
175 subjects. GFR, glomerular filtration rate.
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with eGFR lower than the median value (56 ml/min/
1.73 m2) only in the anemic subgroup had a higher inci-
dence of the future development of anemia than those with
eGFR ≥56 ml/min/1.73 m2 (Figure 4, middle top and mid-
dle bottom). Patients with the presence of proteinuria had
higher incidences of the future development of anemia
than those without proteinuria only in the anemic sub-
group (Figure 4, right top and right bottom). In addition,
when all patients were divided into 4 risk groups according
to median renal RI value and the presence or absence of
proteinuria (group 1: renal RI ≤0.70 and no proteinuria,
group 2: renal RI ≤0.70 and proteinuria, group 3: renal RI
>0.70 and no proteinuria, and group 4: renal RI >0.70 and
proteinuria), group 1 had a significantly lower risk for theFigure 3 Box and whisker plots showing the relationship
between renal resistive index and hemoglobin level in each
stage of CKD. RI, resistive index; GFR, glomerular filtration rate.future development of anemia than groups 3 and 4, and
group 4 had a significantly higher risk than the other 3
groups (Figure 5).
Discussion
We demonstrated for the first time that renal RI was inde-
pendently associated with hemoglobin level in patients with
hypertension. Furthermore, high renal RI and the presence
of proteinuria predicted the future development of anemia
after correcting for confounding factors including age and
diabetes mellitus in the present study.
According to Japan’s 2011 National Nutrition Survey,
anemia was diagnosed in 8.9% of men and 8.5% of
women aged 60-69 in the general population [24]. In the
present study, however, the prevalence of anemia was as
high as 37% in men and 34% in women in this study
population. Renal damage secondary to hypertension isTable 2 Univariate and stepwise multivariate regression
of factors that correlate with hemoglobin levels
Univariate Multivariate
β p value β p value
Age -0.36 <0.01
Male sex 0.26 <0.01 0.26 <0.01
Body mass index 0.16 0.03 0.16 0.02
Diastolic blood pressure 0.25 <0.01
Pulse pressure -0.19 0.01
Resistive index -0.40 <0.01 -0.29 <0.01
Estimated GFR 0.35 <0.01 0.25 <0.01
Qualitative urine protein -0.26 <0.01
RAAS inhibitors -0.18 0.02
Calcium channel blockers -0.24 <0.01
GFR, glomerular filtration rate; RAAS, renin-angiotensin-aldosterone system.
Table 3 Cox proportional hazards regression for the development of anemia
Univariate Multivariate
Hazard ratio p value Hazard ratio p value
Age 1.04 (1.01-1.06) <0.01 1.03 (1.00-1.06) 0.03
Male sex 1.02 (0.61-1.69) 0.95 1.07 (0.63-1.84) 0.80
Diabetes mellitus 1.65 (1.06-2.55) 0.03 1.43 (0.89-2.30) 0.14
Anemia at baseline 1.31 (0.86-2.00) 0.22 0.67 (0.40-1.11) 0.12
Resistive index (per 0.05) 1.30 (1.16-1.46) <0.01 1.18 (1.02-1.37) 0.03
Estimated GFR 0.99 (0.97-1.00) 0.11 1.00 (0.98-1.01) 0.57
Qualitative urine protein 2.21 (1.44-3.39) <0.01 1.80 (1.08-3.01) 0.03
GFR, glomerular filtration rate.
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sclerosis and glomerular sclerosis [10]. Chronic exposure
to high blood pressure initially causes endothelial dysfunc-
tion and progressive infiltration of macrophages and T cells
to the perivascular interstitium. Interactions of these cells
and their cytokines with parenchymal cells cause interstitial
fibrosis and tubular insufficiency [7-10]. In recent studies,
EPO-producing cells were identified in the renal tubuloin-
terstitium surrounding the central vessels [4,5]. Unfavor-
able changes in the interstitial microenvironment such as
inflammation, oxidative stress and ischemia resulting from
hypertension can impair the function of EPO-producing
cells. Recently, Souma et al. demonstrated that the pheno-
typic transition of EPO-producing cells to non-EPO-
producing myofibroblasts is modulated by inflammatoryFigure 4 Kaplan–Meier curves for new anemia in the non-anemic sub
group (bottom) stratified by median renal RI (>0.70 and ≤0.70, left), m
presence or absence of proteinuria (right). RI, resistive index; eGFR, estimmolecules, and suggested the connection between anemia
and renal fibrosis in CKD in a mouse model [6]. Therefore,
the development of CKD secondary to hypertension ought
to affect hematopoiesis even in the earlier stages of CKD
defined by eGFR. Indeed, there was a significant difference
in the hemoglobin levels between patients with renal RI
higher than the median value (0.70) and those with renal
RI ≤0.7 only in the subgroup of 30 ≤ eGFR <60 ml/min/
1.73 m2.
We further demonstrated that renal RI and urine pro-
tein predicted the future development of anemia. Renal
RI reflects the severity of vascular and tubulointerstitial
lesions, and has been shown to correlate with an inflam-
matory state [13-15,25]. We also found that there was
no relationship between the change in hemoglobin levelgroup (top), and further development of anemia in the anemic
edian eGFR (<55 and ≥55 ml/min/1.73 m2, middle), and the
ated glomerular filtration rate.
Figure 5 Kaplan–Meier analysis showing the development of
anemia in the 4 groups according to their renal resistive index
(RI) values and the presence or absence of proteinuria (group 1:
renal RI ≤0.70 and no proteinuria, group 2: renal RI ≤0.70 and
proteinuria, group 3: renal RI >0.70 and no proteinuria, and
group 4: renal RI >0.70 and proteinuria).
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findings may suggest that baseline renal RI and urine
protein, rather than worsening glomerular function de-
fined by eGFR, had a greater impact on the development
of anemia. Although it would be difficult to identify the
underlying mechanisms responsible for the development
of anemia precisely, damage of renal interstitial compart-
ments and arteriosclerosis may contribute to the disease
process independently of glomerular function, especially
in the early stages of CKD defined by eGFR. The causal
interrelationship between the progression of CKD and the
development of anemia warrants further investigation.
We also demonstrated that the presence of proteinuria
is a powerful independent predictor of the future devel-
opment of anemia. Proteinuria is an important sign of
CKD, which can result from hypertension, diabetes mel-
litus and diseases that cause inflammation in the kid-
neys. It is recognized that proteins abnormally filtered
across the glomerular barrier have intrinsic renal toxicity
linked to their over-reabsorption by proximal tubular
cells and activation of tubular-dependent pathways of
interstitial inflammation and fibrosis [26,27]. Protein
overload causes a dose-dependent increase in nuclear
factor kappa beta activation in proximal tubular cells
that leads to myofibroblast transformation of EPO-
producing cells [6,28,29]. We demonstrated that patients
with high renal RA and proteinuria had the greatest risk
for the future development of anemia. The relationship
between proteinuria and renal RI as causal mechanismsunderlying the future development of anemia in CKD
warrants further investigation. It has been reported that
the risk of anemia in patients with diabetes mellitus is
approximately two to three times that of the general
population with the same level of eGFR due to tubuloin-
terstitial injury secondary to proteinuria and dysglycemia
[30]. Diabetes mellitus is commonly found in patients
with hypertension and vice versa. In the present study,
52% of patients had diabetes mellitus, and diabetic patients
had a higher prevalence of proteinuria than non-diabetic
ones. It is difficult to discriminate proteinuria secondary to
diabetic nephropathy from that independent of diabetes
mellitus per se. However, the presence of proteinuria was
independently associated with the future development of
anemia after correcting for diabetes mellitus in the present
study.
The presence of anemia is known to result in a worse
prognosis in terms of both morbidity and mortality. An
earlier diagnosis and optimal treatment of anemia would
reduce incidence rates of cardiovascular diseases, as well
as slow the decline of renal function [31]. Measuring
renal RI in addition to conventional markers of renal
damage including eGFR and urine protein will help cli-
nicians to decide whether or not the anemia is secondary
to renal damage, especially in the early stages of CKD.
In addition, high renal RI may aid in alerting them to
monitor hemoglobin levels even if patients have no sign
of anemia or advanced renal failure on the basis of
eGFR.
The limitations of this study include the small sample
size and the retrospective nature of the data collection.
Renal ultrasonography was performed for the screening
of renal artery stenosis and the evaluation of renal ar-
teriosclerosis at the physician’s discretion on the basis of
the patients’ age, comorbidity and disease characteristics.
Accordingly, the prevalence of coexisting atherosclerotic
diseases in patients who were enrolled in the present
study can be higher than that of hypertensive patients
among the general population. This selection bias may
influence the relationship between renal RI and anemia,
and the clinical impact of renal RI on the future develop-
ment of anemia. Renal RI reflects systemic vascular stiff-
ness as well as renal arteriolosclerosis. Indeed, we found a
statistically significant positive correlation between renal
RI and pulse pressure, one of the surrogate measures of
large artery stiffness. Risk factors for systemic atheroscler-
osis such as inflammation and oxidative stress may affect
renal RI and anemia via different pathways, which can
confound precise understanding of the causal mechanism
underlying the anemia in patients with hypertension and
renal damage. However, stepwise multivariate linear re-
gression analyses revealed that renal RI but not pulse pres-
sure was independently associated with hemoglobin level.
We were unable to obtain sufficient information to
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metabolism, erythropoietin productivity and responsive-
ness, and inflammation. Iron deficiency is common in pa-
tients with CKD. Estrella et al. found that 42.6% of
patients who had both anemia and CKD with eGFR be-
tween 15 and 59 ml/min/1.73 m2 were classified as having
functional or absolute iron-deficiency anemia (33.5% and
9.1%, respectively) [32]. Therefore, patients in the anemic
group and even in the non-anemic group can have varying
degrees of iron deficiency. The causal relationships be-
tween iron status and anemia in the hypertensive popula-
tion, especially those with renal damage, warrant further
investigation. Artunc and Risler reported that the correl-
ation between hemoglobin level and EPO concentration
was gradually attenuated with increasing stages of CKD
and was mostly lost in CKD stages 4 and 5 in an observa-
tional study, indicating the presence of more prominent
EPO deficiency in advanced CKD [2]. In other words, the
pathogenesis of anemia in the early stages of CKD might
be heterogeneous in terms of the severity of impairment
of EPO productivity and responsiveness. Inflammation
also influences EPO efficacy and production as well as
renal atherosclerosis. Urine proteins were qualified by
using a dipstick test in the present study. Therefore, the
potential contribution of microalbuminuria to the
pathogenesis of anemia, especially in patients with dia-
betes, was not investigated. The analysis of markers of
tubulointerstitial damage such as beta-2 microglobulins
or N-acetylglucosaminidase was also not carried out.
Several factors including obesity-related obstructive
sleep apnea, current smoking and COPD may contribute
to persistent or intermittent hypoxia that lead to red cell
production via EPO stimulation. Indeed, body mass index
was positively related to hemoglobin level in the present
study. However, the presence and severity of sleep apnea
and their contribution to hemoglobin level were not
assessed in the present study. Finally, follow-up data of
renal RI, urine protein, and changes in nutritional status
and medication were not included in our outcome
evaluation.
Conclusion
In conclusion, renal RI correlated directly with hemoglobin
levels and contributed to the development of anemia inde-
pendently of glomerular function. The measurement of
renal RI in patients with hypertension can be useful for
elucidating the pathogenesis of anemia and for inferring its
potential risk.
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